3 beta-hydroxysteroid dehydrogenase deficiency: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For patient information click [[{{ | '''For patient information, click [[{{PAGENAME}} (patient information)|here]].''' | ||
{{3 beta-hydroxysteroid dehydrogenase deficiency}} | {{3 beta-hydroxysteroid dehydrogenase deficiency}} | ||
Revision as of 19:41, 8 August 2017
For patient information, click here.
|
3 beta-hydroxysteroid dehydrogenase deficiency Microchapters |
|
Differentiating 11β-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
3 beta-hydroxysteroid dehydrogenase deficiency On the Web |
|
American Roentgen Ray Society Images of 3 beta-hydroxysteroid dehydrogenase deficiency |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
|
Risk calculators and risk factors for 3 beta-hydroxysteroid dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Synonyms and keywords: Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency; 3 beta-hydroxysteroid dehydrogenase deficient congenital adrenal hyperplasia
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 21-hydroxylase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters